Influenza Vaccine Market 2023 by Regions(Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
Influenza Vaccine Market 2023 by Regions(Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
ID : MRI39861 | Date : Feb, 2021 | Pages :
178 | Region : Global |
Publisher : 99 Strategy
The Influenza Vaccine market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Influenza Vaccine market size is expected to gain market growth in the forecast period of 2023 to 2028, with a CAGR of xx%% in the forecast period of 2023 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Competitive Landscape and Influenza Vaccine Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan
Product Type Coverage (Market Size Forecast, Major Company of Product Type etc.):
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Others
By Application
Children
Adults
Elderly
Pregnancy
Influenza Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Influenza Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Influenza Vaccine sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Influenza Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Influenza Vaccine markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Influenza Vaccine market.
Region Coverage (Regional Production, Demand Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Influenza Vaccine market for the forecast period 2023 - 2028?
• What are the driving forces in the Influenza Vaccine market for the forecast period 2023 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Influenza Vaccine industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Influenza Vaccine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Influenza Vaccine Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.2 America Market Size and Growth
Figure America Influenza Vaccine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Influenza Vaccine Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Influenza Vaccine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaInfluenza Vaccine Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Influenza Vaccine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Influenza Vaccine Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Influenza Vaccine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Influenza Vaccine Market Forecast and Growth Rate, 2021-2026(Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Influenza Vaccine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Influenza Vaccine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Influenza Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure Global Influenza Vaccine Revenue Share by Type in 2020 (Million USD)
Table Global Influenza Vaccine Production Volume by Type, 2015-2020 (Volume)
Figure Global Influenza Vaccine Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Influenza Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Influenza Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Influenza Vaccine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Influenza Vaccine Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Influenza Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table Global Influenza Vaccine Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Influenza Vaccine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Influenza Vaccine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Influenza Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure Europe Influenza Vaccine Revenue Share by Type in 2020 (Million USD)
Table Europe Influenza Vaccine Production Volume by Type, 2015-2020 (Volume)
Figure Europe Influenza Vaccine Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Influenza Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Influenza Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Influenza Vaccine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Influenza Vaccine Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Influenza Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Influenza Vaccine Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Influenza Vaccine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Influenza Vaccine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Influenza Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure America Influenza Vaccine Revenue Share by Type in 2020 (Million USD)
Table America Influenza Vaccine Production Volume by Type, 2015-2020 (Volume)
Figure America Influenza Vaccine Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Influenza Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Influenza Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
Table America Influenza Vaccine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Influenza Vaccine Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Influenza Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table America Influenza Vaccine Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Influenza Vaccine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Influenza Vaccine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Influenza Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure Asia Influenza Vaccine Revenue Share by Type in 2020 (Million USD)
Table Asia Influenza Vaccine Production Volume by Type, 2015-2020 (Volume)
Figure Asia Influenza Vaccine Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Influenza Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Influenza Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Influenza Vaccine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Influenza Vaccine Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Influenza Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Influenza Vaccine Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Influenza Vaccine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Influenza Vaccine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Influenza Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Influenza Vaccine Revenue Share by Type in 2020 (Million USD)
Table Oceania Influenza Vaccine Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Influenza Vaccine Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Influenza Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Influenza Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Influenza Vaccine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Influenza Vaccine Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Influenza Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Influenza Vaccine Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Influenza Vaccine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Influenza Vaccine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Influenza Vaccine Revenue by Type, 2015-2020 (Million USD)
Figure Africa Influenza Vaccine Revenue Share by Type in 2020 (Million USD)
Table Africa Influenza Vaccine Production Volume by Type, 2015-2020 (Volume)
Figure Africa Influenza Vaccine Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Influenza Vaccine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Influenza Vaccine Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Influenza Vaccine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Influenza Vaccine Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Influenza Vaccine Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Influenza Vaccine Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Influenza Vaccine Production Forecast
Figure Global Influenza Vaccine Revenue and Growth Rate Forecast 2021-2026(Million USD)
Figure Global Influenza Vaccine Production Volume and Growth Rate Forecast 2021-2026(Volume)
8.2 Global Influenza Vaccine Forecast by Type
Table Global Influenza Vaccine Revenue by Type, 2021-2026(Million USD)
Figure Global Influenza Vaccine Revenue Share by Type in 2026 (Million USD)
Table Global Influenza Vaccine Production Volume by Type, 2021-2026(Volume)
Figure Global Influenza Vaccine Production Volume Share by Type in 2026 (Volume)
8.3 Global Influenza Vaccine Forecast by End-Use (2021E-2026F)
Table Global Influenza Vaccine Consumption Value by End-Use, 2021-2026(Million USD)
Figure Global Influenza Vaccine Consumption Value Share by End-Use in 2026 (Million USD)
Table Global Influenza Vaccine Consumption Volume by End-Use, 2021-2026(Volume)
8.4 Global Influenza Vaccine Forecast by Region (2021E-2026F)
Table Global Influenza Vaccine Consumption Value by Region, 2021-2026(Million USD)
Figure Global Influenza Vaccine Consumption Value Share by Region in 2026 (Million USD)
Table Global Influenza Vaccine Consumption Volume by Region, 2021-2026(Volume)
Figure Global Influenza Vaccine Consumption Volume Share by Region in 2026 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 GSK
9.1.1 GSK Profile
Table GSK Overview List
9.1.2 GSK Products & Services
9.1.3 GSK Company Dynamics & News
9.1.4 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Sinovac
9.2.1 Sinovac Profile
Table Sinovac Overview List
9.2.2 Sinovac Products & Services
9.2.3 Sinovac Company Dynamics & News
9.2.4 Sinovac Business Operation Conditions
Table Business Operation of Sinovac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Changsheng
9.3.1 Changsheng Profile
Table Changsheng Overview List
9.3.2 Changsheng Products & Services
9.3.3 Changsheng Company Dynamics & News
9.3.4 Changsheng Business Operation Conditions
Table Business Operation of Changsheng (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 CCBIO
9.4.1 CCBIO Profile
Table CCBIO Overview List
9.4.2 CCBIO Products & Services
9.4.3 CCBIO Company Dynamics & News
9.4.4 CCBIO Business Operation Conditions
Table Business Operation of CCBIO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Aleph Biomedical
9.5.1 Aleph Biomedical Profile
Table Aleph Biomedical Overview List
9.5.2 Aleph Biomedical Products & Services
9.5.3 Aleph Biomedical Company Dynamics & News
9.5.4 Aleph Biomedical Business Operation Conditions
Table Business Operation of Aleph Biomedical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Sanofi
9.6.1 Sanofi Profile
Table Sanofi Overview List
9.6.2 Sanofi Products & Services
9.6.3 Sanofi Company Dynamics & News
9.6.4 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Lanzhou Institute Of Biological Product
9.7.1 Lanzhou Institute Of Biological Product Profile
Table Lanzhou Institute Of Biological Product Overview List
9.7.2 Lanzhou Institute Of Biological Product Products & Services
9.7.3 Lanzhou Institute Of Biological Product Company Dynamics & News
9.7.4 Lanzhou Institute Of Biological Product Business Operation Conditions
Table Business Operation of Lanzhou Institute Of Biological Product (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Siobp
9.8.1 Siobp Profile
Table Siobp Overview List
9.8.2 Siobp Products & Services
9.8.3 Siobp Company Dynamics & News
9.8.4 Siobp Business Operation Conditions
Table Business Operation of Siobp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Hualan Bio
9.9.1 Hualan Bio Profile
Table Hualan Bio Overview List
9.9.2 Hualan Bio Products & Services
9.9.3 Hualan Bio Company Dynamics & News
9.9.4 Hualan Bio Business Operation Conditions
Table Business Operation of Hualan Bio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Tianyuan Bio-Pharma
9.10.1 Tianyuan Bio-Pharma Profile
Table Tianyuan Bio-Pharma Overview List
9.10.2 Tianyuan Bio-Pharma Products & Services
9.10.3 Tianyuan Bio-Pharma Company Dynamics & News
9.10.4 Tianyuan Bio-Pharma Business Operation Conditions
Table Business Operation of Tianyuan Bio-Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Vaxtec
9.11.1 Vaxtec Profile
Table Vaxtec Overview List
9.11.2 Vaxtec Products & Services
9.11.3 Vaxtec Company Dynamics & News
9.11.4 Vaxtec Business Operation Conditions
Table Business Operation of Vaxtec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Hissen
9.12.1 Hissen Profile
Table Hissen Overview List
9.12.2 Hissen Products & Services
9.12.3 Hissen Company Dynamics & News
9.12.4 Hissen Business Operation Conditions
Table Business Operation of Hissen (Sales Revenue, Cost, Gross Margin)
9.13 Abbott
9.13.1 Abbott Profile
Table Abbott Overview List
9.13.2 Abbott Products & Services
9.13.3 Abbott Company Dynamics & News
9.13.4 Abbott Business Operation Conditions
Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Novartis
9.14.1 Novartis Profile
Table Novartis Overview List
9.14.2 Novartis Products & Services
9.14.3 Novartis Company Dynamics & News
9.14.4 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
9.15 Tasly&Jenner
9.15.1 Tasly&Jenner Profile
Table Tasly&Jenner Overview List
9.15.2 Tasly&Jenner Products & Services
9.15.3 Tasly&Jenner Company Dynamics & News
9.15.4 Tasly&Jenner Business Operation Conditions
Table Business Operation of Tasly&Jenner (Sales Revenue, Cost, Gross Margin)
9.16 Tiantan
9.16.1 Tiantan Profile
Table Tiantan Overview List
9.16.2 Tiantan Products & Services
9.16.3 Tiantan Company Dynamics & News
9.16.4 Tiantan Business Operation Conditions
Table Business Operation of Tiantan (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Influenza Vaccine Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Influenza Vaccine Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Influenza Vaccine Sales Volume by Companies, 2015-2020E (Volume)
Table Global Influenza Vaccine Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Influenza Vaccine Market Concentration Ratio in 2020E
Figure America Influenza Vaccine Market Concentration Ratio in 2020E
Figure Asia Influenza Vaccine Market Concentration Ratio in 2020E
Figure Oceania Influenza Vaccine Market Concentration Ratio in 2020E
Figure Africa Influenza Vaccine Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Influenza Vaccine INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Influenza Vaccine INDUSTRY SUMMARY & CONCLUSION
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.